Magnesiocard

Recall | Medicines | 19/03/2013

The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been detected in a batch of the drug "Magnesium Verla i.v./i.m. Injection Solution" from Verla-Pharm Arzneimittel GmbH & Co. KG, which is only approved in Germany, was found to be microbiologically contaminated. Since the medicinal product approved in Austria was manufactured in an analogous manufacturing process by the same contract manufacturer, all packages of this medicinal product currently in circulation or in transit are being recalled as a precautionary measure.

Name of the medicinal product Magnesiocard i.v. - Ampullen
Marketing authorisation number(s) 1-18609
Marketing authorisation holder Kwizda Pharma GmbH
Batch number(s) 100001, 110001, 120001
Classification of the recall2
BASG reference number INS-640.001-0692
Email

Further inquiry note